Matthew Ottmer is our Chief Operating Officer. He brings to Voyager more than 18 years of biotechnology industry experience, including executive leadership of business operations, product development, and commercialization across multiple therapeutic areas and all stages of development. Mr. Ottmer joins Voyager most recently from Momenta Pharmaceuticals, Inc., where he was Chief Operating Officer, responsible for program and alliance management, research, clinical development, pharmaceutical sciences and commercial activities since late 2015. Prior to this role, he spent 16 years at Biogen, Inc., in a variety of leadership roles, including as Senior Vice President, Strategy and Emerging Businesses, Head of Tysabri Business, Chief of Staff to the Chief Executive Officer, President of Syntonix Pharmaceuticals, Inc. (a wholly owned subsidiary of Biogen, now Bioverativ, Inc.), and Vice President of Global Operations. Mr. Ottmer received a Bachelor of Arts in Political Science from the University of Michigan and a Masters of Business Administration from Northwestern University’s Kellogg School of Management.

science